IDO1 and head and neck squamous cell carcinoma: >500 IDO+expressing cells/mm2 in 17/27 HNSCC specimens, IDO expressed by tumour cells and infiltrating immune cells in 12/27 (44%) cases (range 5%‐95% tumour cells+)